Incidental 11C-Choline PET/CT Brain Uptake due to Meningioma in a Patient Studied for Prostate Cancer
Authors:
- 1 November 2013
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (11) , e435-e437
Abstract
We report a case of a 75-year-old male patient treated with radiotherapy in 1999 for prostate cancer. Due to a rise in prostate-specific antigen, he underwent (11)C-choline PET/CT. The study was negative for secondary lesions but revealed an incidental pathologic focal brain uptake. A subsequent magnetic resonance examination confirmed the presence of a brain lesion typical for meningioma.Keywords
This publication has 7 references indexed in Scilit:
- The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic reviewAnnals of Nuclear Medicine, 2012
- Positron Emission Tomography Imaging of Meningioma in Clinical PracticeNeurosurgery, 2012
- Meningioma: review of the literature with emphasis on the approach to radiotherapyExpert Review of Anticancer Therapy, 2011
- Comparison of MRI, F-18 FDG, and 11C-Choline PET/CT for Their Potentials in Differentiating Brain Tumor Recurrence From Brain Tumor Necrosis Following RadiotherapyClinical Nuclear Medicine, 2011
- 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancerNuclear Medicine Communications, 2010
- C-11 Choline Versus F-18 Fluorodeoxyglucose for Imaging MeningiomasClinical Nuclear Medicine, 2009
- Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005